PhAST Corp. is developing a rapid diagnostic technology that utilizes single-cell imaging to provide real-time, actionable data about microorganisms. This innovative approach focuses on closely analyzing individual cells to enhance the speed and accuracy of pathogen detection and antibiotic susceptibility testing.